scholarly journals What will be the role of I-123 MIBG in improving the outcome of medically treated heart failure patients?

2012 ◽  
Vol 19 (6) ◽  
pp. 1198-1205 ◽  
Author(s):  
Fahad Waqar ◽  
Stephanie H. Dunlap ◽  
Myron C. Gerson
2010 ◽  
Vol 6 (2) ◽  
pp. 33 ◽  
Author(s):  
Christopher R deFilippi ◽  
G Michael Felker ◽  
◽  

For many with heart failure, including the elderly and those with a preserved ejection fraction, both risk stratification and treatment are challenging. For these large populations and others there is increasing recognition of the role of cardiac fibrosis in the pathophysiology of heart failure. Galectin-3 is a novel biomarker of fibrosis and cardiac remodelling that represents an intriguing link between inflammation and fibrosis. In this article we review the biology of galectin-3, recent clinical research and its application in the management of heart failure patients.


2013 ◽  
Vol 61 (10) ◽  
pp. E735
Author(s):  
Savina Nodari ◽  
Marco Triggiani ◽  
Laura Lupi ◽  
Alessandra Manerba ◽  
Giuseppe Milesi ◽  
...  

Open Heart ◽  
2017 ◽  
Vol 4 (2) ◽  
pp. e000632 ◽  
Author(s):  
Jodi McCoy ◽  
Matthew Bates ◽  
Christopher Eggett ◽  
Mario Siervo ◽  
Sophie Cassidy ◽  
...  

2020 ◽  
Vol 75 (11) ◽  
pp. 955
Author(s):  
Andrea D'Amato ◽  
Paolo Severino ◽  
Mariateresa Pucci ◽  
Lucrezia Netti ◽  
Fabio Infusino ◽  
...  

2018 ◽  
Vol 49 (3) ◽  
pp. 198-204 ◽  
Author(s):  
Mauro Feola ◽  
Marzia Testa ◽  
Cinzia Ferreri ◽  
Marco Cardone ◽  
Mario Sola ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document